Navigation Links
MIV Therapeutics Announces Renowned Researcher to Detail Milestone,Pre-Clinical Results at Prominent International Conference EuroPCR,2007

ebsite.html. To read or download MIV Therapeutics' Investor Fact Sheet, visit http://www.trilogy-capital.com/tcp/mivt/factsheet.html. To obtain daily and historical Company stock quote data, and recent Company news releases, visit http://www.trilogy-capital.com/tcp/html/mivt.htm. MIVT is traded on the Frankfurt, Germany, stock exchange under the symbol MIV.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Such statements are indicated by words or phrases such as "proposed," "expected," "believe," "will," "breakthrough," "significant," "indicated," "feel," "revolutionary," "should," "ideal," "extremely" and "excited." These statements are made under "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties including, without limitation, the potential for the unsuccessful closing by the Company of its Vascore acquisition, together with the raising of funding sufficient to continue with its operations and those contemplated by the Company as a consequence thereof, and the ability of the Company to raise sufficient funding and to continue to develop its various business interests as presently contemplated. See the Company's filings with the Securities and Exchange Commission including, without limitation, the Company's recent Form 10-K and Form 10-Qs, which identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.

Contact

MIV Therapeutics Inc.
Investor Relations, 604-301-9545, x14
Toll-free: 800-221-5108
Fax: 604-301-9546
investor@mivtherapeutics.com





Page: 1 2 3 4

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:6/3/2015)... , June 3, 2015 MEDTEC China South 2015 came ... of MEDTEC China 2015, MEDTEC China South has been recognized ... out as a key event for the medical device manufacturing ... years of challenges, this year marks the successful return of the ... after the event first debuted there in 2005. ...
(Date:6/3/2015)...   Health Data Consortium (HDC) , a public-private partnership whose mission ... to improve health and healthcare, today announced Niall Brennan ... Office of Enterprise Data and Analytics at the Centers ... of this year,s Health Data Liberators Award ... ways to help improve the quality and value of ...
(Date:6/3/2015)...  Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a ... expertise in opioid antagonists, announced today that Adapt ... overdose with intranasal naloxone, has commenced a rolling ... the United States Food and Drug Administration (FDA) ... drug intended to treat opioid overdose.  A rolling ...
Breaking Medicine Technology:MEDTEC Successfully Returns to Southern China 2MEDTEC Successfully Returns to Southern China 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 2CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 3CMS Chief Data Officer and Health Data Advocate Niall Brennan Receives Third Annual Health Data Liberators Award 4Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 2Lightlake Therapeutics Inc. Announces Adapt Pharma Limited Commences Rolling NDA Submission To The FDA For Intranasal Naloxone 3
... 18, 2011 Reportlinker.com announces that a ... its catalogue: China ... http://www.reportlinker.com/p0590608/China-Contract-Research-Organization-CRO-Industry-Report-2010-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc ... high R&D costs of new drugs worldwide, ...
... from Texas has invented a miraculous new medical laser ... inventions and scientific advancements in modern history. The miraculous ... organs to kill harmful germs and bacteria during surgical ... currently contribute to the estimated 100,000 annual deaths attributed ...
Cached Medicine Technology:China Contract Research Organization (CRO) Industry Report, 2010-2011 2China Contract Research Organization (CRO) Industry Report, 2010-2011 3China Contract Research Organization (CRO) Industry Report, 2010-2011 4China Contract Research Organization (CRO) Industry Report, 2010-2011 5New Life Saving Medical Invention Announced by Perry Felix 2
(Date:6/3/2015)... June 03, 2015 “ Harmony ” was ... takes a look at the latest and coolest applications on ... host of AppWatch and technology expert, conducted the app review ... that wants to improve some aspect of their life. , ... only for people with difficulties in their life. However, hypnotherapy ...
(Date:6/3/2015)... 03, 2015 Follow us on ... has revolutionized disease treatment on account of their better ... diseases, such as rheumatoid arthritis. The industry is expected ... traditional small molecule drugs to biopharmaceuticals over the coming ... cell and gene therapies, and recombinant proteins has attracted ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 On the heels ... $13 billion industry by 2020 ( click here to ... computer scientists believe Baltimore has the talent to ... in which genetic code and other biological data are collected ... disease. “Baltimore contains all the elements of a perfect ...
(Date:6/3/2015)... 03, 2015 Dr. Steven Reisman, a nationally ... Center ( http://www.newyorkcardiac.com ) located in NYC, announced today the ... his practice. In most cases, depending on the level of ... they call, they will be seen by a cardiologist that ... a cardiologist is to ensure that people who have an ...
(Date:6/3/2015)... WA (PRWEB) June 03, 2015 ... insurance exchange technology, has announced that CEO Jonathan Rickert ... Institute 2015 on June 4, 2015. The session ... digital technologies are disrupting traditional business models in health ... business value. , WHAT: Digital Transformation and the ...
Breaking Medicine News(10 mins):Health News:An Application to Enjoy Hypnotherapy Sessions at Home was featured on NewsWatch Television 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:NYC Cardiologist, Dr. Steven Reisman, Announces Same Day and Evening Appointments 2Health News:Array Health’s CEO to Present at America’s Health Insurance Plans Institute 2015 2
... which diet would work best for you, study suggests , WEDNESDAY, ... cut carbs or fats to lose weight? A DNA test using ... you, new research suggests. , Researchers from Stanford University used data ... women were assigned to one of four popular diets for a ...
... , ... ... ... ...
... ... ... ... ...
... Ill. -- A daily dose of vitamin D may just ... according to researchers at Loyola University Chicago Marcella Niehoff School ... months when days are short and more time is spent ... despite the nutrient,s widely reported health benefits," said Sue Penckofer, ...
... youth means trouble by mid-40s, despite activity levels, study finds , ... in their 20s and 30s are more apt to develop heart ... people who spent less time in front of the screen, a ... the worse news is that you can,t exercise the risk away. ...
... , ... ... ... ...
Cached Medicine News:Health News:A Cheek Swab to Choose Your Diet Plan? 2Health News:A Cheek Swab to Choose Your Diet Plan? 3Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 2Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 3Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 4Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 5Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 6Health News:Saks 5th Ave, By Kilian, Versace, Barefoot Wine & Bubbly, GL Homes, Bluefly and NUVO Support Women On The Move's 'Unveil Your Pink' Event! 7Health News:Aspen Dental Announces Results of Its 'An Hour for Haiti' Employee Donation Program 2Health News:Aspen Dental Announces Results of Its 'An Hour for Haiti' Employee Donation Program 3Health News:Vitamin D lifts mood during cold weather months 2Health News:You Can't Exercise Away TV's Toll on the Heart 2Health News:You Can't Exercise Away TV's Toll on the Heart 3Health News:Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock 2Health News:Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock 3
... The VERSAPORT™ RT cannulas are all able ... systems packaged for use with the RT ... are all able to be used with ... with the RT system. The trocars include: ...
... trocar has a sharp linear blade and a ... VERSAPORT™ PLUS V2 trocar is available in 5 ... 5 mm-12 mm long sizes with a radiolucent ... has a sharp linear blade and a spring-loaded ...
... Auto Suture™ SPRING-GRIP™ single use nonconductive anchoring ... mm, 11 mm and 12 mm sizes ... and 5 mm, 5 mm-10 mm, 5 ... mm-15 mm sizes for use with the ...
... Access ...unlike any trocar system you've ever ... actually four systems in one designed ... adaptive to all of your needs., ... or dilating tip styles, OnePort™ can effectively ...
Medicine Products: